Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
First episode of depression before age 25
Be younger than 65 years old
Must not have
Use of medications that may interact with light to produce a photoallergic reaction
Timeline
Screening 3 weeks
Treatment Varies
Follow Up score between baseline and follow up (8 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial will help to clarify the mechanisms underlying the antidepressant effects of phototherapy and will provide valuable information about the potential role of sleep in the antidepressant response to bright light therapy.
Who is the study for?
This trial is for young people with depression who have had their first episode before age 25 and are currently seeking treatment. They must have a certain score on a depression scale to join. People can't participate if they've taken certain medications recently, have other major psychiatric disorders, work night shifts, travel across time zones often, abuse substances, or have conditions that react badly to light.
What is being tested?
The study tests whether special glasses emitting phototherapy light can improve symptoms of depression in young individuals by altering their sleep-wake cycle. It explores the idea that those with delayed sleep patterns may benefit more from this therapy.
What are the potential side effects?
Potential side effects include eye strain or discomfort and skin reactions due to bright light exposure. However, these effects are generally mild and not common.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My first depression episode was before I turned 25.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not taking any medications that react badly to light.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ score between baseline and follow up (8 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~score between baseline and follow up (8 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Associations between Changes in Sleep-Wake Profile and Changes in Severity of Depression
Associations between Initial Sleep-Wake Profile and Changes in Severity of Depression
Fatigue Severity
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PhototherapyExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of SydneyOTHER
198 Previous Clinical Trials
335,946 Total Patients Enrolled
5 Trials studying Depression
1,125 Patients Enrolled for Depression
University of OttawaLead Sponsor
218 Previous Clinical Trials
269,444 Total Patients Enrolled
12 Trials studying Depression
1,481 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a condition affected by bright light.I haven't taken any sleep or alertness affecting meds in the last month, except for stable antidepressants or stimulants.My first depression episode was before I turned 25.I am currently receiving or about to start treatment for a mood disorder.I am not taking any medications that react badly to light.I have a condition that could be causing my depression or sleep issues.
Research Study Groups:
This trial has the following groups:- Group 1: Phototherapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger